Login / Signup

Liver damage profile in COVID-19 pregnant patients.

Marcin JanuszewskiLaura Ziuzia-JanuszewskaMichal KudanKamil PlutaJakub KlapaczyńskiWaldemar WierzbaTomasz MaciejewskiAlicja A JakimiukArtur J Jakimiuk
Published in: Cell communication and signaling : CCS (2024)
Hepatic damage in pregnant women with COVID-19 is a common, mild, transaminase-dominant, or mixed type of injury, and often correlates with elevated inflammatory markers. SARS-CoV-2 test should be performed as a part of differential diagnosis in elevated liver function tests. Although bile acids serum levels were commonly elevated they seems to be clinically irrelevant in terms of pregnancy outcomes. Video Abstract.
Keyphrases
  • sars cov
  • pregnant women
  • pregnancy outcomes
  • coronavirus disease
  • respiratory syndrome coronavirus
  • ejection fraction
  • newly diagnosed
  • prognostic factors